SimBioSys takes in $15m Series A

Chicago-based SimBioSys, a simulation-based, precision medicine platform, has raised $15 million in Series A funding.

Chicago-based SimBioSys, a simulation-based, precision medicine platform, has raised $15 million in Series A funding. Genoa Ventures and Northpond Ventures led the round with participation from AV8 Ventures, Heritage Medical Group, and Mayo Clinic.

Source: Press Release